(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALLERMI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALLERMI

ST13

US500000097843222

Class

5

Filing

97843222

Registration

7560594

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

11/05/2024

Trademark type

Word

Nice classes

5

Filing date

03/16/2023

Registration date

11/05/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/05/2024

Last transaction

11/05/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-01-00

First use in commerce

2022-07-00

Drawing code

4

Owner type

03

Owner location

San Francisco, CA, US

Examiner

IP, KENNINA NGA-YU

Law office

N30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Allermi, Inc.

Representatives

Dax Alvarez SNELL & WILMER L.L.P.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Allergy medications for human use; nasal spray preparations for human use

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/05/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

11/05/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/03/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/03/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

08/31/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

08/31/2024

IUAF

USE AMENDMENT FILED

07/02/2024

EISU

TEAS STATEMENT OF USE RECEIVED

07/02/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

07/02/2024

CHPB

POST PUBLICATION AMENDMENT - ENTERED

06/03/2024

APET

ASSIGNED TO PETITION STAFF

06/03/2024

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

05/22/2024

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

04/16/2024

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

04/11/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/12/2024

PUBO

PUBLISHED FOR OPPOSITION

03/12/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/21/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/02/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/22/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/21/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/19/2023

GNRT

NON-FINAL ACTION E-MAILED

12/19/2023

CNRT

NON-FINAL ACTION WRITTEN

12/19/2023

DOCK

ASSIGNED TO EXAMINER

12/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/08/2023

NWAP

NEW APPLICATION ENTERED

03/20/2023

Continuous trademark protection

Get notified about every new filing that threatens ALLERMI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.